Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

271.63 +4.58 (+1.72%)

Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Sleep Apnea Device Maker Resmed Sees Improved Relative Strength ↗

January 14, 2022

Resmed shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Via Investor's Business Daily

This Company Just Made a Possibly Lucrative Acquisition — What's Next? ↗

January 14, 2022

Photo by Ccfb on Pixabay This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. The global...

Via Benzinga

What 4 Analyst Ratings Have To Say About ResMed ↗

January 13, 2022

Within the last quarter, ResMed (NYSE:RMD) has observed the following analyst ...

Via Benzinga

Take Action To Unlock Supply Chain Disruption Issues ↗

January 07, 2022

Businesses are grappling with supply chain disruption. And beating this challenge requires leaders to take decisive action right now.

Via Investor's Business Daily

4 Low-Beta Stocks To Buy For A Volatile Market ↗

December 08, 2021

Global economic uncertainty, inflationary pressure, a disappointing jobs report, and concerns around the COVID-19 Omicron variant are fostering market volatility. So, against this backdrop, we think it...

Via Talk Markets

Notable Resmed Insider Trades $2.9M In Company Stock ↗

November 16, 2021

Robert Douglas President And Chief Operating Officer, Resmed Inc., COO at Resmed (NYSE:RMD), made a large buy and sell of company shares on November 15, according to a new SEC...

Via Benzinga

Earnings Scheduled For October 28, 2021 ↗

October 28, 2021

Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2022 ↗

January 13, 2022

Upgrades According to Morgan Stanley, the prior rating for SunPower Corp (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021 ↗

December 06, 2021

Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX:

Via Benzinga

CNBC's Final Trades: Fiserv, ResMed, Monster Beverage And This Semiconductor Company ↗

November 16, 2021

On CNBC’s “Halftime Report Fina...

Via Benzinga

Global Home Medical Equipment Market Size Is Estimated To Reach $56 Billion By 2027

November 09, 2021

Palm Beach, FL – November 9, 2021 – FinancialNewsMedia.com News Commentary – Over the last few years, and with the ‘help’ of the pandemic, home health care medical equipment industry has surged. Home...

Via FinancialNewsMedia

ResMed (RMD) Q1 2022 Earnings Call Transcript ↗

October 29, 2021

RMD earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs ↗

October 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug ↗

October 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...

Via Benzinga

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

3 Leading Healthcare Stocks to Buy in 2021 and Beyond ↗

October 19, 2021

Three healthcare stocks that have momentum on their side and are good buys right now.

Via The Motley Fool

3 Healthcare Stocks to Buy and Hold for the Next 10 Years ↗

September 30, 2021

Consistency is the main attraction for these companies.

Via The Motley Fool

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗

September 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

Chief Administrative Officer Of Resmed Makes $434.44 Thousand Sell ↗

September 07, 2021

David Pendarvis, Chief Administrative Officer at Resmed (NYSE:RMD), made a large insider sell on September 3, according to a new SEC filing. What Happened: A Form 4 filing from...

Via Benzinga

Topics Regulatory Compliance

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

President Of Resmed Makes $689.53 Thousand Sell ↗

September 02, 2021

James Hollingshead, President of Resmed (NYSE:RMD), made a large insider sell on September 1, according to a new SEC filing. What Happened: A Form 4 filing from the U.S....

Via Benzinga

Topics Regulatory Compliance

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

Stocks That Hit 52-Week Highs On Wednesday ↗

August 18, 2021

Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs. Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market cap basis to set a new...

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗

August 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...

Via Benzinga

Stocks That Hit 52-Week Highs On Monday ↗

August 23, 2021

Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

August 20, 2021

Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high...

Via Benzinga

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗

August 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.